Advancing international standards for diagnostics and biobanking
BBMRI.at experts contribute to the development of international quality standards through its active involvement in ISO/TC 212 – Medical laboratories and in vitro diagnostic systems. Cornelia Stumptner from the Medical University of Graz leads or co-leads the development of ISO/TS 18701, addressing pre-examination processes for isolated microbiome DNA, and ISO 24051-2, covering digital pathology and artificial intelligence (AI)-based image analysis. This work helps advance standards relevant to medical laboratories, biobanks and molecular diagnostics.
BBMRI.at experts contribute to international standardisation
International standards help ensure the quality, reliability and comparability of biological samples and diagnostic results. Through its involvement in ISO/TC 212 — Medical laboratories and in vitro diagnostic systems, BBMRI.at supports the development of standards relevant to biobanks, medical laboratories and molecular diagnostics. The work on the microbiome technical specifications and the interaction with ISO is also part to the EU-funded MICROBE project, to strengthen the exchange between European research initiatives and international standardisation efforts.
The committee’s work is organised into five working groups: WG 1 — Quality and competence in the medical laboratory; WG 2 — Reference systems; WG 3 — In vitro diagnostic products; WG 4 — Microbiology and molecular diagnostics; and WG 5 — Laboratory biorisk management.
Cornelia Stumptner of the Medical University of Graz contributes particularly to WG 4 — Microbiology and molecular diagnostics. She leads or co-leads the development of
- ISO/TS 18701, Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for human specimens — Isolated microbiome DNA,
- ISO 24051-2, Medical laboratories — Part 2: Digital pathology and artificial intelligence (AI)-based image analysis.
At the meeting, she presented updates on the work of the expert teams developing these standards.
Progress on standards for pre-examination processes
One important development is ISO/TS 18701, which addresses pre-examination processes for human specimens intended for isolated microbiome DNA analysis. The project has advanced towards the New Proposal (NP) ballot stage. It is intended to replace the current European technical specification CEN/TS 17626.
Pre-examination procedures—including sample collection, handling, transport, processing and storage—can significantly affect the quality and reliability of diagnostic results. Clear, internationally agreed requirements help minimise pre-analytical variability and support reproducible laboratory testing.
Further work is planned on several standards in the ISO 20186 series, covering pre–examination processes for venous whole blood used in molecular in vitro diagnostic examinations: ISO 20186-1: Isolated cellular RNA; ISO 20186-2: Isolated genomic DNA; and ISO 20186-3: Isolated circulating cell-free DNA from plasma. Â Project leaders have been identified, with further work expected to begin in the coming years.
Future work is also anticipated on ISO/TS 18702: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for exosomes and other extracellular vesicles in venous whole blood — DNA, RNA and proteins and ISO 18703: Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Isolated circulating cell free RNA from plasma, once ISO 18701 is close to publication.
Digital pathology, AI and next-generation sequencing
Alongside pre-examination standards, WG4 is advancing work in other areas relevant to medical laboratories. ISO 24051-2, which covers digital pathology and AI-based image analysis, is in the Draft International Standard (DIS) ballot phase until January 2027, as reported by Cornelia Stumptner.
Two standards addressing next-generation sequencing (NGS) workflows are also in the DIS ballot phase until December 2026: ISO 25379-1, covering human DNA examinations, and ISO 25379-2, covering human RNA examinations.
Strengthening quality across biobanking and diagnostics
Through its contributions to ISO/TC 212, BBMRI.at helps connect biobanking expertise with international standardisation and supports the BBMRI-ERIC strategic objective SO8.2 Global Standardization Initiatives”, as outlined in the BBMRI-ERIC Work Programme 2025–2027. This objective is co-led by the Austrian and Polish BBMRI Nodes. The development of consistent requirements for sample quality, pre-examination processes and diagnostic workflows supports reliable research and improves the comparability of results across laboratories and countries.
Further information:Â